These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18216754)

  • 21. Microbial contamination of nebulizers in the home treatment of cystic fibrosis.
    Blau H; Mussaffi H; Mei Zahav M; Prais D; Livne M; Czitron BM; Cohen HA
    Child Care Health Dev; 2007 Jul; 33(4):491-5. PubMed ID: 17584406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ozone disinfection of home nebulizers effectively kills common cystic fibrosis bacterial pathogens.
    Towle D; Baker V; Schramm C; O'Brien M; Collins MS; Feinn R; Murray TS
    Pediatr Pulmonol; 2018 May; 53(5):599-604. PubMed ID: 29542874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of Nebulizer Drying for Patients With Cystic Fibrosis.
    Moore JE; Moore RE; Bell J; Millar BC
    Respir Care; 2020 Oct; 65(10):1443-1450. PubMed ID: 32209705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of Staphylococcus aureus (MSSA and MRSA) to drying: implications for nebulizer hygiene in patients with cystic fibrosis.
    Moore JE; Millar BC
    J Hosp Infect; 2020 Jun; 105(2):366-367. PubMed ID: 32298736
    [No Abstract]   [Full Text] [Related]  

  • 25. Fungal contamination of nebuliser devices used by people with cystic fibrosis.
    Peckham D; Williams K; Wynne S; Denton M; Pollard K; Barton R
    J Cyst Fibros; 2016 Jan; 15(1):74-7. PubMed ID: 26104996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stenotrophomonas maltophilia contamination of nebulizers used to deliver aerosolized therapy to inpatients with cystic fibrosis.
    Denton M; Rajgopal A; Mooney L; Qureshi A; Kerr KG; Keer V; Pollard K; Peckham DG; Conway SP
    J Hosp Infect; 2003 Nov; 55(3):180-3. PubMed ID: 14572484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The disinfection of nebulizers in a basic health unit in Ribeirão Preto].
    Balthazar MB; Santos BM
    Rev Esc Enferm USP; 1997 Apr; 31(1):23-35. PubMed ID: 9220847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiome Profiles of Nebulizers in Hospital Use.
    Swanson CS; Dhand R; Cao L; Ferris J; Elder CS; He Q
    J Aerosol Med Pulm Drug Deliv; 2022 Aug; 35(4):212-222. PubMed ID: 35230145
    [No Abstract]   [Full Text] [Related]  

  • 29. A day in the life of a nebulizer: surveillance for bacterial growth in nebulizer equipment of children with cystic fibrosis in the hospital setting.
    O'Malley CA; VandenBranden SL; Zheng XT; Polito AM; McColley SA
    Respir Care; 2007 Mar; 52(3):258-62. PubMed ID: 17328823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contamination of the nebulization systems used in the prophylaxis with amphotericin B nebulized in lung transplantation.
    Monforte V; Román A; Gavaldà J; Bravo C; Rodriguez V; Ferrer A; Pahissa A; Morell F
    Transplant Proc; 2005 Nov; 37(9):4056-8. PubMed ID: 16386625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cleaning home nebulizers used by patients with cystic fibrosis: is rinsing with tap water enough?
    Rosenfeld M; Joy P; Nguyen CD; Krzewinski J; Burns JL
    J Hosp Infect; 2001 Nov; 49(3):229-30. PubMed ID: 11716644
    [No Abstract]   [Full Text] [Related]  

  • 32. Vibrating-mesh nebulizer maintenance by CF patients: Results from a French survey.
    Baravalle-Einaudi M; Dufeu N; Dupont C; Vecellio L; Delaisi B; Carsin A; Dubus JC;
    Pulm Pharmacol Ther; 2017 Jun; 44():57-60. PubMed ID: 28315491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design principles of liquid nebulization devices currently in use.
    Rau JL
    Respir Care; 2002 Nov; 47(11):1257-75; discussion 1275-8. PubMed ID: 12425742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cleaning and infection control of airway clearance devices used by CF patients.
    Manor E; Gur M; Geffen Y; Bentur L
    Chron Respir Dis; 2017 Nov; 14(4):370-376. PubMed ID: 28513198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Home nebulizer use among patients with cystic fibrosis.
    Rosenfeld M; Emerson J; Astley S; Joy P; Williams-Warren J; Standaert TA; Yim DL; Crist D; Thykkuttathil M; Torrence M; FitzSimmons S; Ramsey B
    J Pediatr; 1998 Jan; 132(1):125-31. PubMed ID: 9470013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nebulizer use and maintenance by cystic fibrosis patients: a survey study.
    Lester MK; Flume PA; Gray SL; Anderson D; Bowman CM
    Respir Care; 2004 Dec; 49(12):1504-8. PubMed ID: 15571641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low level of bacterial contamination of mist tents used in home treatment of cystic fibrosis patients.
    Jakobsson B; Hjelte L; Nyström B
    J Hosp Infect; 2000 Jan; 44(1):37-41. PubMed ID: 10633052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nebulizer performance: AFLM study. Association Française de Lutte contre la Mucoviscidose.
    Faurisson F; Dessanges JF; Grimfeld A; Beaulieu R; Kitzis MD; Peytavin G; Lefebvre JP; Farinotti R; Sautegeau A
    Respiration; 1995; 62 Suppl 1():13-8. PubMed ID: 7792434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Water filters can prevent Stenotrophomonas maltophilia contamination of nebuliser equipment used by people with cystic fibrosis.
    Woodhouse R; Peckham DG; Conway SP; Denton M
    J Hosp Infect; 2008 Apr; 68(4):371-2. PubMed ID: 18353498
    [No Abstract]   [Full Text] [Related]  

  • 40. Qualitative analysis of microbial contamination of inhalers.
    Mabbott FA; Mullen AB; Smith A; Smith G; Boyter AC
    J Hosp Infect; 2011 Mar; 77(3):277-8. PubMed ID: 21277652
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.